Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease

Reproductive Sciences

Volumn 19, Issue 11, 2012, Pages 1154-1162

  MacKlaim, Jean M ^a,b   Cohen, Craig R ^c   Donders, Gilbert ^d   Gloor, Gregory B ^a,b   Hill, Janet E ^e   Parham, Groesbeck P ^f   Ravel, Jacques ^g   Spear, Gregory ^h   Van De Wijgert, Janneke ⁱ   Reid, Gregor ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Femicare vzw   (Belgium)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

^f CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h RUSH UNIVERSITY MEDICAL CENTER   (United States)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Amsel; bacteria; cervicovagina; diagnosis; gardnerella; lactobacillus; microbiome; Nugent; vaginosis

Indexed keywords

PROBIOTIC AGENT;

BACTERIAL STRAIN; DEVELOPING COUNTRY; DIAGNOSTIC TEST; GARDNERELLA INFECTION; GYNECOLOGIC CARE; HEALTH CARE ACCESS; HIGH THROUGHPUT SEQUENCING; HUMAN; MICROBIOME; MORBIDITY; NONHUMAN; PATIENT EDUCATION; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; UTERINE CERVIX DISEASE; VAGINA DISEASE; VAGINA FLORA; VAGINITIS; WOMEN'S HEALTH;

BACTERIA; CERVIX UTERI; FEMALE; GENITAL DISEASES, FEMALE; HEALTH EDUCATION; HUMANS; METAGENOME; PROBIOTICS; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84867559040     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112446075     Document Type: Review

References (59)

1. Hummelen R, Fernandes AD, Macklaim JM, et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One. 2010 ; 5 (8). e12078
2. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011 ; 108 (suppl 1). 4680-4687
3. Oakley BB, Fiedler TL, Marrazzo JM, Fredricks DN. Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol. 2008 ; 74 (15). 4898-4909
4. Hill JE, Goh SH, Money DM, et al. Characterization of vaginal microflora of healthy, nonpregnant women by chaperonin-60 sequence-based methods. Am J Obstet Gynecol. 2005 ; 193 (3 pt 1). 682-692
5. Kim TK, Thomas SM, Ho M, et al. Heterogeneity of vaginal microbial communities within individuals. J Clin Microbiol. 2009 ; 47 (4). 1181-1189
6. Gajer P, Brotman RM, Bai G, Sakamoto J, SchÜtte UME, Zhong X, Koenig SSK, Fu L, Ma Z, Zhou X, Abdo Z, Forney LJ, Ravel J. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4 :
7. Zhou X, Brotman RM, Gajer P, et al. Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect Dis Obstet Gynecol. 2010 ; 737425: 2010
8. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001 ; 32 (1). 37-41
9. Brotman RM, Ravel J, Cone RA, Zenilman JM. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect. 2010 ; 86 (4). 297-302
10. Reid G, Zorzitto ML, Bruce AW, Jewett MAS, Chan RCY, Costerton JW. The pathogenesis of urinary tract infection in the elderly: the role of bacterial adherence to uroepithelial cells. Curr Microbiol. 1984 ; 11 (2). 67-72
11. Nicolle LE, Zhanel GG, Harding GK. Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria. World J Urol. 2006 ; 24 (1). 61-65
12. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005 ; 353 (18). 1899-1911
13. Donders GG, Vereecken A, Bosmans E, et al. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 2002 ; 109 (1). 34-43
14. Donders GG. Microscopy of the bacterial flora on fresh vaginal smears. Infect Dis Obstet Gynecol. 1999 ; 7 (4). 177-179
15. Cervical Cancer Screening in Developing Countries. Geneva, Switzerland: World Health Organization ; 2002 :
16. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983 ; 74 (1). 14-22
17. Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955 ; 69 (5). 962-976
18. Sodhani P, Garg S, Bhalla P, Singh MM, Sharma S, Gupta S. Prevalence of bacterial vaginosis in a community setting and role of the pap smear in its detection. Acta Cytol. 2005 ; 49 (6). 634-638
19. Fiscella K, Klebanoff MA. Are racial differences in vaginal pH explained by vaginal flora?. Am J Obstet Gynecol. 2004 ; 191 (3). 747-750
20. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol. 1991 ; 29 (2). 297-301
21. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ. 1994 ; 308 (6924). 295-298
22. Spiegel CA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis by direct Gram stain of vaginal fluid. J Clin Microbiol. 1983 ; 18 (1). 170
23. Burton JP, Devillard E, Cadieux PA, Hammond JA, Reid G. Detection of Atopobium vaginae in post menopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol. 2004 ; 42 (4). 1829-1831
24. Larsson PG, Carlsson B, Fåhraeus L, Jakobsson T, Forsum U. Diagnosis of bacterial vaginosis: need for validation of microscopic image area used for scoring bacterial morphotypes. Sex Transm Infect. 2004 ; 80 (1). 63-67
25. Chaijareenont K, Sirimai K, Boriboonhirunsarn D, Kiriwat O. Accuracy of Nugent's score and each Amsel's criteria in the diagnosis of bacterial vaginosis. J Med Assoc Thai. 2004 ; 87 (11). 1270-1274
26. Gallo MF, Jamieson DJ, Cu-Uvin S, Rompalo A, Klein RS, Sobel JD. Accuracy of clinical diagnosis of bacterial vaginosis by human immunodeficiency virus infection status. Sex Transm Dis. 2011 ; 38 (4). 270-274
27. Reid G, McGroarty JA, Tomeczek L, Bruce AW. Identification and plasmid profiles of Lactobacillus species from the vagina of 100 healthy women. FEMS Immunol Med Microbiol. 1996 ; 15 (1). 23-26
28. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis. 1996 ; 174 (5). 1058-1063
29. Macklaim J, Gloor GB, Anukam KC, Cribby S, Reid G. At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners. Proc Nat Acad Sci USA. 2011 ; 108 (suppl 1). 4688-4695
30. Mirmonsef P, Zariffard MR, Gilbert D, et al. Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with Toll-like receptor ligands. Am J Reprod Immunol. 2011 ;:
31. Kirjavainen PK, Laine RM, Carter D, Hammond JA, Reid G. Expression of anti-microbial defense factors in vaginal mucosa following exposure to Lactobacillus rhamnosus GR-1. Int J Probiotics. 2008 ; 3: 99-106
32. Cauci S, Guaschino S, De AD, et al. Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod. 2003 ; 9 (1). 53-58
33. Dahn A, Saunders S, Anukam KC, et al. Vaginal gene expression changes and Lactobacillus presence in women treated with oral Premarin estrogen replacement therapy. Microbes Infect. 2008 ; 10 (6). 620-627
34. Hummelen R, Macklaim JM, Bisanz JE, et al. Vaginal microbiome diversity and epithelial cell changes in post-menopausal women with dryness and atrophy. PLoS One. 2011 ; 6 (11). e26602
35. Spear GT, Gilbert D, Sikaroodi M, Doyle L, Green L, Gillevet PM, Landay AL, Veazey RS. Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection. AIDS Res Hum Retroviruses.. 2010 Feb ; 26 (2). 193-200
36. Schellenberg J.J., Links M.G., Hill J.E., et al. Molecular definition of vaginal microbiota in East African commercial sex workers. Appl. Environ. Microbiol. 2011 ; 77 (12). 4066-4074
37. Yeoman CJ, Yildirim S, Thomas SM, et al. Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential. PLoS One. 2010 ; 5 (8). e12411
38. Harwich MD, Alves JM, Buck GA, et al. Drawing the line between commensal and pathogenic Gardnerella vaginalis through genome analysis and virulence studies. BMC Genomics. 2010 ; 11: 375
39. Mirmonsef P, Gilbert D, Veazey RS, Wang J, Kendrick SR, Spear GT. A comparison of lower genital tract glycogen and lactic acid levels in women and Macaques: implications for HIV and SIV susceptibility. AIDS Res Hum Retroviruses. 2011 ;:
40. MacPhee RA, Hummelen R, Bisanz JE, Miller WL, Reid G. Probiotic strategies for the treatment and prevention of bacterial vaginosis. Expert Opin Pharmacother. 2010 ; 11 (18). 2985-2995
41. Li J, Wang W, Xu SX, et al. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc Natl Acad Sci USA. 2011 ; 108 (8). 3360-3365
42. McMillan A, Dell M, Zellar MP, et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011 ; 86 (1). 58-64
43. Hummelen R, Changalucha J, Butamanya NL, Cook A, Habbema JDF, Reid G. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. Int J Gynecol Obstet. 2010 ; 111 (3). 245-248
44. Petricevic L, Unger FM, Viernstein H, Kiss H. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2008 ; 141 (1). 54-57
45. Ngugi BM, Hemmerling A, Bukusi EA, et al. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05. Sex Transm Dis. 2011 ; 38 (11). 1020-1027
46. Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011 ; 52 (10). 1212-1217
47. Antonio MA, Meyn LA, Murray PJ, Busse B, Hillier SL. Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous lactobacilli. J Infect Dis. 2009 ; 199 (10). 1506-1513
48. Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG. 2005 ; 112 (2). 234-240
49. Donders GG, Van BB, Van de Walle P, et al. Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor(R)) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study. Gynecol Obstet Invest. 2010 ; 70 (4). 264-272
50. Parent D, Bossens M, Bayot D, et al. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Arzneimittelforschung. 1996 ; 46 (1). 68-73
51. Liu JJ, Reid G, Jiang Y, Turner MS, Tsai CC. Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14. Cell Microbiol. 2007 ; 9 (1). 120-130
52. Vangelista L, Secchi M, Liu X, et al. Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers. Antimicrob Agents Chemother. 2010 ; 54 (7). 2994-3001
53. Cohen CR, Brown J, Moscicki AB, et al. A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel) in healthy young women administered twice daily for 14 days. PLoS One. 2011 ; 6 (1). e16258
54. Veldhuijzen NJ, Vyankandondera J, van de Wijgert JH. HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda. AIDS.. 2010 ; 24 (14). 2289-92
55. Perisić Z, Perisić N, Golocorbin Kon S, et al. The influence of probiotics on the cervical malignancy diagnostics quality. Vojnosanit Pregl.. 2011 ; 68 (11). 956-60
56. Hemmerling A, Harrison W, Schroeder A, et al. Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Sex Transm Dis. 2009 ; 36 (9). 564-569
57. Liao YM, Yang CY, Kao CC, et al. Prevalence and impact on quality of life of lower urinary tract symptoms among a sample of employed women in Taipei: a questionnaire survey. Int J Nurs Stud. 2009 ; 46 (5). 633-644
58. Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JS, Parham GP. Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ. 2008 ; 86 (8). D - E
59. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, et al. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med. 2011 ; 8 (5). e1001032